Clinical validation testing proved CleaRecon DL’s 3D image reconstructions to be effective at reducing unwanted artifacts, offering clearer images in 98% of cases.

Researchers have used a state-of-the-art microscope and advanced AI to track clotting risks in CAD patients. The goal is to spot blood clots before they even happen, ensuring patients are prescribed the right therapy for their specific needs. 

Why do investors equate these companies with beautiful, mythical beasts? Because startups with such dazzling attributes are—or long were—rarely seen.

Where a cautious President Biden wanted to confine American AI know-how to America, a freewheeling President Trump wants to turn it loose—at least to select friends and allies.

Leaders with the publicly traded, Los Angeles-based organization discussed the possibility during RadNet’s first quarter earnings call on Monday. 

In 2016, Geoffrey Hinton famously said, “People should stop training radiologists now,” believing it was “completely obvious” AI would outperform human rads within five years. 

Members of the specialty shared their advice in a special report published by the Radiological Society of North America's journal Radiology: Artificial Intelligence. 

The program provides detailed assessments of how algorithms implemented into workflows are impacting efficiency and outcomes.